logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Severe Pain

    FiltersReset Filters
    8 results

    • butrans

      (buprenorphine)
      Purdue Pharma LP
      Usage: BUTRANS is indicated for managing severe and persistent pain requiring long-term opioid treatment when other options are insufficient. It is not for as-needed use and is reserved for patients who cannot tolerate or have inadequate relief from alternative treatments due to the risks of addiction and overdose.

    • fentanyl transdermal

      (fentanyl transdermal)
      SpecGx LLC
      Usage: Fentanyl transdermal system is indicated for managing severe, persistent pain in opioid-tolerant patients requiring long-term opioid therapy when other treatments are inadequate. It is not meant for as-needed use and carries risks of addiction and misuse.

    • hydromorphone hydrochloride

      (HYDROMORPHONE HYDROCHLORIDE)
      Hospira, Inc.
      Usage: Hydromorphone Hydrochloride Injection is indicated for severe pain management requiring an opioid analgesic when alternative treatments are inadequate. It is recommended for patients who cannot tolerate or achieve adequate relief from non-opioid analgesics or combination products, with caution due to risks of addiction and misuse.

    • hydromorphone hydrochloride

      (Hydromorphone Hydrochloride)
      Trigen Laboratories, LLC
      Usage: Hydromorphone hydrochloride extended-release tablets are indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. They are not intended for as-needed use and should be reserved for patients who are opioid-tolerant due to associated risks of addiction and overdose.

    • hysingla er

      (hydrocodone bitartrate)
      Purdue Pharma LP
      Usage: HYSINGLA ER is indicated for managing severe, persistent pain that necessitates long-term opioid treatment when alternative therapies are inadequate. It should be reserved for patients unable to tolerate non-opioid analgesics or immediate-release opioids due to concerns about addiction, abuse, and misuse. It is not for as-needed use.

    • methadone hydrochloride

      (Methadone Hydrochloride)
      Hikma Pharmaceuticals USA Inc.
      Usage: Methadone Hydrochloride Oral Solution is indicated for managing severe, persistent pain when other treatments are inadequate, and for detoxification and maintenance treatment of opioid addiction. It is not for as-needed pain relief and should only be used when other options have been ineffective or intolerable.

    • nucynta

      (tapentadol hydrochloride)
      Collegium Pharmaceutical, Inc.
      Usage: NUCYNTA ER (tapentadol) is indicated for managing severe, persistent pain in adults requiring long-term opioid treatment when alternatives are inadequate. It is also indicated for severe neuropathic pain associated with diabetic peripheral neuropathy in adults under similar circumstances. It is not intended for as-needed use.

    • oxycontin

      (oxycodone hydrochloride)
      Purdue Pharma LP
      Usage: OXYCONTIN is indicated for the management of severe, persistent pain in adults and opioid-tolerant pediatric patients aged 11 and older requiring long-term opioid analgesia when alternative treatments are inadequate. It is not intended for as-needed use due to risks of addiction and overdose.